13F 申报指南13F 概念全攻略
什么是 SEC Form 13F 申报？美股机构大户持股全攻略
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制，学会如何追踪顶级对冲基金与机构法人持仓动向。
AlphaSMO 权威研究指南阅读专题
CIK: 0001913464
申报总市值
US$1.2亿
US$1.2亿
230 檔
14.1%
在 Q3 2024 申报期间，AlphaCentric Advisors LLC（CIK: 0001913464）向美国 SEC 提交的 Form 13F 报告显示，其追踪之股票投资组合总市值达 US$1.2亿，共持有 230 个公开申报仓位。
AlphaCentric Advisors LLC 在 Q3 2024 进行了结构性的板块轮动与仓位换股。在开立 14 个全新仓位及加仓 8 档持股的同时，亦同步清仓 12 档并减仓 13 档标的。
在资产配置集中度方面，AlphaCentric Advisors LLC 的前 5 大核心持股（包含 RITM, HRMY, LKFT 等）合计占整体申报市值的 14.1%，反映机构在主要关键仓位上的权重分布。
仅显示前 200 大持股（共 230 只）
| # | 代码 | 标的名称 | 资产子类别 | 占比 | 占比变动 | 持仓量变化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | RITM | Rithm Capital CORP | 股票-房地产 | 3.21% | — | — | |
| 2 | HRMY | Harmony Biosciences Holdings | 股票-其他 | 2.88% | — | -20.49% | |
| 3 | LKFT | Lakefront Biotherapeutic-adr | 股票-其他 | 2.32% | — | — | |
| 4 | MRK | Merck & Co. Inc. | 股票-医疗保健 | 2.03% | — | — | |
| 5 | EFC | Ellington Financial Inc | 股票-其他 | 1.93% | — | — | |
| 6 | NBIX | Neurocrine Biosciences Inc | 股票-医疗保健 | 1.93% | +0.13% | +221.43% | |
| 7 | MTG | Mgic Investment CORP | 股票-金融 | 1.89% | — | -13.11% | |
| 8 | ARGX | Argenx Se - Adr | 股票-医疗保健 | 1.81% | +0.11% | -37.93% | |
| 9 | INDV | Indivior Pharmaceuticals, Inc. | 股票-其他 | 1.76% | — | — | |
| 10 | DX | Dynex Capital Inc | 股票-其他 | 1.72% | — | — | |
| 11 | BMRN | Biomarin Pharmaceutical Inc | 股票-医疗保健 | 1.70% | — | +96.97% | |
| 12 | SRPT | Sarepta Therapeutics Inc | 股票-医疗保健 | 1.67% | — | +140.00% | |
| 13 | DVAX | Dynavax Technologies CORP | 股票-其他 | 1.67% | — | +55.00% | |
| 14 | UTHR | United Therapeutics CORP | 股票-医疗保健 | 1.66% | — | -56.90% | |
| 15 | RWT | Redwood Trust Inc | 股票-其他 | 1.66% | — | — | |
| 16 | AM6 | Amicus Therapeutics Inc | 股票-其他 | 1.63% | — | +1.23% | |
| 17 | MFA | Mfa Financial Inc | 股票-其他 | 1.59% | — | — | |
| 18 | ATEC | Alphatec Holdings Inc | 股票-其他 | 1.53% | — | — | |
| 19 | EXK | Exact Sciences CORP | 股票-原材料 | 1.52% | — | — | |
| 20 | QQQ | Invesco Qqq Trust Series 1 | ETF-科技型 | 1.52% | +1.16% | NEW | |
| 21 | QQQM | Invesco Nasdaq 100 ETF | ETF-科技型 | 1.52% | +1.16% | NEW | |
| 22 | RPRX | Royalty Pharma plc | 股票-医疗保健 | 1.42% | — | +12.50% | |
| 23 | MIRM | Mirum Pharmaceuticals Inc | 股票-其他 | 1.30% | — | -29.69% | |
| 24 | JAZZ | Jazz Pharmaceuticals plc | 股票-医疗保健 | 1.28% | +0.07% | +40.91% | |
| 25 | MITT | Tpg Mortgage Investment Trus | 股票-其他 | 1.17% | — | — | |
| 26 | ACT | Enact Holdings Inc | 股票-其他 | 1.14% | — | — | |
| 27 | ELS | Equity Lifestyle Properties | 股票-房地产 | 1.09% | — | — | |
| 28 | ITCIEUR | Intra-cellular Therapies Inc | 股票-其他 | 1.09% | — | — | |
| 29 | AMPH | Amphastar Pharmaceuticals In | 股票-其他 | 1.08% | — | +20.00% | |
| 30 | VRNA | Verona Pharma PLC - Adr | 股票-其他 | 1.07% | — | -10.71% | |
| 31 | GSK | Gsk Plc-spon Adr | 股票-医疗保健 | 1.06% | — | — | |
| 32 | APLSUSD | Apellis Pharmaceuticals Inc | 股票-其他 | 1.02% | — | — | |
| 33 | ADAM | Adamas Trust Inc | 股票-其他 | 0.95% | — | — | |
| 34 | RVNCEUR | Revance Therapeutics Inc | 股票-其他 | 0.95% | — | — | |
| 35 | ONC | Beone Medicines Ltd-adr | 股票-其他 | 0.92% | — | -63.33% | |
| 36 | STXS | Stereotaxis Inc | 股票-其他 | 0.91% | -0.23% | — | |
| 37 | ENOV | Enovis CORP | 股票-其他 | 0.88% | — | +37.50% | |
| 38 | TWO 6.25 01-15-26债券 | Two Harbors Inv CORP | 债券 | 0.88% | — | — | |
| 39 | ROIV | Roivant Sciences Ltd. | 股票-医疗保健 | 0.86% | +0.13% | +13.64% | |
| 40 | GPCR | Structure Therapeutics Inc | 股票-其他 | 0.85% | — | — | |
| 41 | TAK | Takeda Pharmaceutic-sp Adr | 股票-医疗保健 | 0.85% | — | — | |
| 42 | PTGX | Protagonist Therapeutics Inc | 股票-其他 | 0.84% | — | — | |
| 43 | CATX | Perspective Therapeutics Inc | 股票-其他 | 0.79% | — | -2.44% | |
| 44 | CLDX | Celldex Therapeutics Inc | 股票-其他 | 0.76% | — | -36.84% | |
| 45 | PFE | Pfizer Inc | 股票-医疗保健 | 0.75% | — | -75.00% | |
| 46 | SNY | Sanofi-adr | 股票-医疗保健 | 0.75% | -0.16% | — | |
| 47 | IMVT | Immunovant Inc | 股票-其他 | 0.74% | — | -4.11% | |
| 48 | LNTH | Lantheus Holdings Inc | 股票-医疗保健 | 0.73% | — | — | |
| 49 | PMT 5.5 11-01-24债券 | Pennymac CORP | 债券 | 0.71% | — | — | |
| 50 | AXSM | Axsome Therapeutics Inc | 股票-医疗保健 | 0.70% | +0.26% | -30.00% |
| # | 代码 | 标的名称 | 占比变动 | 持仓量变化 | 异动类型 |
|---|---|---|---|---|---|
| 1 | MRK | Merck & Co. Inc. | +2% | NEW | 新建仓 |
| 2 | INDV | Indivior Pharmaceuticals, Inc. | +1.8% | NEW | 新建仓 |
| 3 | ATEC | Alphatec Holdings Inc | +1.5% | NEW | 新建仓 |
| 4 | NBIX | Neurocrine Biosciences Inc | +1.2% | +221.43% | 加仓 |
| 5 | APLSUSD | Apellis Pharmaceuticals Inc | +1% | NEW | 新建仓 |
| 6 | TAK | Takeda Pharmaceutic-sp Adr | +0.9% | NEW | 新建仓 |
| 7 | SRPT | Sarepta Therapeutics Inc | +0.8% | +140.00% | 加仓 |
| 8 | LNTH | Lantheus Holdings Inc | +0.7% | NEW | 新建仓 |
| 9 | BMRN | Biomarin Pharmaceutical Inc | +0.7% | +96.97% | 加仓 |
| 10 | DVAX | Dynavax Technologies CORP | +0.6% | +55.00% | 加仓 |
| 11 | EXK | Exact Sciences CORP | +0.6% | — | 不变 |
| 12 | PEN | Penumbra Inc | +0.6% | NEW | 新建仓 |
| 13 | NUVL | Nuvalent Inc-a | +0.5% | NEW | 新建仓 |
| 14 | MLTX | Moonlake Immunotherapeutics | +0.5% | NEW | 新建仓 |
| 15 | CYTK | Cytokinetics Inc | +0.5% | NEW | 新建仓 |
| 16 | RVNCEUR | Revance Therapeutics Inc | +0.5% | — | 不变 |
| 17 | VRNA | Verona Pharma PLC - Adr | +0.5% | -10.71% | 减仓 |
| 18 | CGNX | Cognex CORP | +0.5% | NEW | 新建仓 |
| 19 | ROK | Rockwell Automation Inc | +0.5% | NEW | 新建仓 |
| 20 | JAZZ | Jazz Pharmaceuticals plc | +0.4% | +40.91% | 加仓 |
| 21 | APGE | Apogee Therapeutics Inc | +0.4% | NEW | 新建仓 |
| 22 | QQQM | Invesco Nasdaq 100 ETF | +0.4% | +28.60% | 加仓 |
| 23 | QQQ | Invesco Qqq Trust Series 1 | +0.4% | +28.40% | 加仓 |
| 24 | KROS | Keros Therapeutics Inc | +0.4% | NEW | 新建仓 |
| 25 | AMPH | Amphastar Pharmaceuticals In | +0.3% | +20.00% | 加仓 |
| 26 | LKFT | Lakefront Biotherapeutic-adr | +0.3% | — | 不变 |
| 27 | AUPH | Aurinia Pharmaceuticals Inc | -0.3% | EXIT | 清仓 |
| 28 | IWD | Ishares Russell 1000 Value E | -0.4% | EXIT | 清仓 |
| 29 | RPV | Invesco S&p 500 Pure Value E | -0.4% | EXIT | 清仓 |
| 30 | RWT 7.75 06-15-27债券 | Redwood Trust Inc | -0.4% | EXIT | 清仓 |
| 31 | CABA | Cabaletta Bio Inc | -0.4% | EXIT | 清仓 |
| 32 | VKTX | Viking Therapeutics Inc | -0.5% | -78.79% | 减仓 |
| 33 | ARGX | Argenx Se - Adr | -0.5% | -37.93% | 减仓 |
| 34 | SNPS | Synopsys Inc | -0.5% | -50.00% | 减仓 |
| 35 | CLDX | Celldex Therapeutics Inc | -0.5% | -36.84% | 减仓 |
| 36 | NARIUSD | Inari Medical Inc | -0.5% | EXIT | 清仓 |
| 37 | TRML | Tourmaline Bio Inc | -0.6% | -92.67% | 减仓 |
| 38 | ONC | Beone Medicines Ltd-adr | -0.7% | -63.33% | 减仓 |
| 39 | MDT | Medtronic plc | -0.7% | -71.43% | 减仓 |
| 40 | RWT 5.75 10-01-25债券 | Rwt Holdings Inc | -0.7% | EXIT | 清仓 |
| 41 | ACAD | Acadia Pharmaceuticals Inc | -0.7% | -60.00% | 减仓 |
| 42 | AVBP | Arrivent Biopharma Inc | -0.9% | -82.56% | 减仓 |
| 43 | CHRS | Coherus Oncology Inc | -1% | -67.00% | 减仓 |
| 44 | CERE1EUR | Cerevel Therapeutics Holding | -1.3% | EXIT | 清仓 |
| 45 | DCGO | Docgo Inc | -1.5% | EXIT | 清仓 |
| 46 | QURE | uniQure N.V. | -1.5% | EXIT | 清仓 |
| 47 | UTHR | United Therapeutics CORP | -1.7% | -56.90% | 减仓 |
| 48 | PFE | Pfizer Inc | -2.1% | -75.00% | 减仓 |
| 49 | PCRX | Pacira Biosciences Inc | -2.5% | EXIT | 清仓 |
| 50 | BCRX | Biocryst Pharmaceuticals Inc | -3.1% | EXIT | 清仓 |
根据 SEC 官方 Form 13F 申报备案，AlphaCentric Advisors LLC 在 Q3 2024 季度的美股持仓总市值约为 US$1.2亿，共申报了 230 个公开持股仓位。
在 Q3 2024 季度，AlphaCentric Advisors LLC 按市值排列的前三大核心持股分别为：RITM (3.2%)、HRMY (2.9%)、LKFT (2.3%)。其中最大持股仓位 RITM 占据整体投资组合约 3.2% 的权重。
精选 AlphaSMO 大户持股与内部人交易深度分析，提升投资决策胜率
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制，学会如何追踪顶级对冲基金与机构法人持仓动向。
本季最大新建仓标的
MRK
市值: US$272.5万
本季最大获利了结 / 清仓标的
BCRX
前期市值: US$417.2万
在 Q3 2024 季度中，AlphaCentric Advisors LLC 共进行了 47 项持仓异动，包含新建仓 14 个仓位、加仓 8 个仓位、减仓 13 个仓位以及清仓 12 个仓位。 其中最大新建仓标的为 MRK。 本季清仓仓位包含 BCRX。
本页面所有持股数据均直接同步自美国证券交易委员会（SEC）EDGAR 官方系统之 13F-HR / 13F-HR/A 季度申报文件。AlphaSMO 通过机器解析 CUSIP 与个股对照，提供 100% 精准对齐的历史时序数据集，并支持 Schema.org 结构化数据格式。
解析公司高管、董事与 10% 大股东之 Form 4 内部人交易申报，掌握高管自家股票买卖第一手信号。
深入剖析 5% 股权申报门槛、13D 与 13G 之差异，以及最新 SEC 申报时程规范，洞察机构法人的激进投资动向。